Dr. Reddy's Laboratories Ltd. Financials: Quarterly Results
Revenue
8835.5
Cr.
PAT
1409.70
Cr.
EBITDA
1987.80
Cr.
Dr. Reddy's Laboratories Ltd. Q1FY26 Financial Metrics
| Indicator | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 |
|---|---|---|---|---|---|
| Net Sales/Income from operations (Cr.) | 8545.20 | 8506 | 8381.20 | 8038.20 | 7696.10 |
| Total Income From Operations (Cr.) | 8572.10 | 8528.40 | 8381.20 | 8038.20 | 7696.10 |
| P/L Before Interest, Excpt. Items & Tax (Cr.) | 1987.80 | 2065.30 | 1951.80 | 1987 | 1936.50 |
| P/L Before Exceptional Items & Tax (Cr.) | 1904.80 | 1999.70 | 1870.10 | 1911.30 | 1876.70 |
| P/L After Tax from Ordinary Activities (Cr.) | 1409.70 | 1581.20 | 1400 | 1335.80 | 1386.50 |
| Net Profit/Loss For the Period (Cr.) | 1409.70 | 1581.20 | 1400 | 1335.80 | 1386.50 |
| Basic EPS | 17.04 | 19.12 | 16.97 | 80.45 | 83.61 |
FAQs
Dr. Reddy's Laboratories Ltd. announced its quarterly results for Q1 FY2026 on July 23, 2025.
In Q1 FY2026, Dr. Reddy's Laboratories Ltd. are as follows:
Revenue: ₹8835.5 crore
Net Profit: ₹1409.70 crore.
For Q1 FY2026, Dr. Reddy's Laboratories Ltd. posted ₹8835.5 crore in revenue and ₹1409.70 crore in net profit.
Past quarterly results for Dr. Reddy's Laboratories Ltd. can be found on their official Investor Relations page, which includes detailed reports and financial performance summaries.